No image
Anti-tau antibody reduces cognitive decline by 54% in early-stage patients
Anti-tau antibody reduces cognitive decline by 54% in early-stage patients
Quantum algorithms simulate protein-drug interactions 1000× faster than classical methods
Targeted elimination of senescent cells improves physical function in adults 70–85
Engineered insulin formulation achieves 65% bioavailability via the oral route
Cardiac progenitor cells improve ejection fraction and reduce 5-year mortality
AI-guided warfarin dosing reduces major bleeding events by 47% across diverse populations
Engineered nanoparticles deliver therapeutics to brain tumors with 12× greater efficiency
PROTAC molecules selectively eliminate oncogenic proteins in solid tumors
Precision probiotic formulation achieves sustained remission in 78% of Crohn's patients
Machine learning model achieves 94% accuracy in identifying clinically significant interactions